Vlado Perkovic

About Professor Vlado Perkovic

Board Member

  • MBBS,
  • PhD,
  • FASN,
  • FRACP

Vlado Perkovic is Dean of Medicine and Health and Scientia Professor at UNSW Sydney, a Professorial Fellow at The George Institute, Australia, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications.

He has led several major international clinical trials that have identified new treatments to prevent kidney failure. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.

Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training at The Royal Melbourne Hospital. He is a Fellow of the Royal Australasian College of Physicians, the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology. Vlado serves on the Editorial Board of a number of leading journals including the New England Journal of Medicine. 

Vlado joined the Board of Children’s Cancer Institute in March 2020.

WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE eGFR 20-<30 mL/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS

Kidney International Reports Date published:

WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK

Kidney International Reports Date published:

WCN25-1567 Glomerular disease registry and Biobank (GRIT)- design and baseline results

Kidney International Reports Date published:

WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY

Kidney International Reports Date published:

Related Readings